Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

6-benzyl-1-benzyloxymethyl-5-iodouracil

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Uracil
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effects of crystalline state and self-nanoemulsifying drug delivery system (SNEDDS) on oral bioavailability of the novel anti-HIV compound 6-benzyl-1-benzyloxymethyl-5-iodouracil in rats
Abstract The objective of this study was to investigate the effect of crystalline state and a formulation of self-nanoemulsifying… Expand
2017
2017
Identification of cytochrome P450s involved in the metabolism of 6-benzyl-1-benzyloxymethyl-5-iodouracil (W-1) using human recombinant enzymes and rat liver microsomes in vitro
Abstract 1. The aim of this study was to identify the hepatic metabolic enzymes, which involved in the biotransformation of 6… Expand
2016
2016
Profile of disposition, tissue distribution and excretion of the novel anti-human immunodeficiency virus (HIV) agent W-1 in rats
The purpose of this study was to characterize the disposition, distribution, excretion and plasma protein binding of 6-benzyl-1… Expand
2015
2015
Development and validation of a high performance liquid chromatography method for determination of 6-benzyl-1-benzyloxymethyl-5-iodouracil (W-1), a novel non-nucleoside reverse transcriptase…
A sensitive and selective high-performance liquid chromatographic (HPLC) method for determination of 6-benzyl-1-benzyloxymethyl-5… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE